Validation of a novel semi-automated ECG quantification tool, applied to a cardio-oncology
TCM with CalECG-4.2 ensures a high reproducibility while monitoring key parameters like QTc duration and Sokolow-Lyon voltage, making it a reliable and time-saving alternative for the ECG surveillance of drug toxicities in cardio-oncology.
Authors
- Fabio Badilini (ORCID: https://orcid.org/0000-0001-9195-4317)
- Mathieu Jamelot (ORCID: https://orcid.org/0000-0002-3719-3833)
- Edi Prifti (ORCID: https://orcid.org/0000-0001-8861-1305)
- Maxime Robert‐Halabi (ORCID: https://orcid.org/0000-0002-3813-0965)
- Adrien Procureur (ORCID: https://orcid.org/0000-0003-3486-5208)
- Martino Vaglio (ORCID: https://orcid.org/0000-0003-0370-1278)
- Joe‐Elie Salem (ORCID: https://orcid.org/0000-0002-0331-3307)
- S. Cohen (ORCID: https://orcid.org/0000-0001-5462-0625)
Institutions
- Inserm (FR)
- Holy Spirit University of Kaslik (LB)
- Sorbonne Université (FR)
- Nutrition et obésité : approches systémiques (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Pitié-Salpêtrière Hospital (FR)
- Institut de Recherche pour le Développement (FR)
- Hôpital Tenon (FR)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1186/s40959-025-00405-7
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00